icatibant acetate
Icatibant Acetate is a bradykinin b2 receptor antagonist used to treat Hereditary Angioedemas.
Bradykinin B2 Receptor Antagonist · by Nang Kuang Pharm Co
Generic of Firazyr
Key facts
- Active ingredient
- Icatibant Acetate
- Drug class
- Bradykinin B2 Receptor Antagonist
- Form
- Injectable
- Strength
- Icatibant Acetate EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- hereditary angioedemas
- Manufacturer
- Nang Kuang Pharm Co
- FDA application
- ANDA212081
Drug class
May treat (source: NIH RxClass)
See how Icatibant Acetate ranks — best-rated bradykinin b2 receptor antagonist for:
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Icatibant Acetate treat?
- Icatibant Acetate (Icatibant Acetate) may be used to treat hereditary angioedemas, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Icatibant Acetate?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Icatibant Acetate. To pay less, Icatibant Acetate is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Icatibant Acetate?
- Icatibant Acetate is marketed by Nang Kuang Pharm Co. You can see Nang Kuang Pharm Co's full profile, rating, and other products on pharmaranks.
- Is Icatibant Acetate a brand-name or generic drug?
- Icatibant Acetate is a generic medication; its active ingredient is Icatibant Acetate. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Icatibant Acetate available over the counter?
- No. Icatibant Acetate is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Icatibant Acetate come in?
- Icatibant Acetate is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Icatibant Acetate?
- Icatibant Acetate is classified as bradykinin b2 receptor antagonist, per the FDA's Established Pharmacologic Class.
- Is Icatibant Acetate FDA-registered?
- Icatibant Acetate is on record with the U.S. FDA under application number ANDA212081. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Icatibant Acetate
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,308 reports naming Icatibant Acetate, and the FDA flagged 73% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hereditary angioedema546 reports
- weight decreased209 reports
- weight increased208 reports
- abdominal distension97 reports
- gastrointestinal disorder78 reports
- stress70 reports
- swelling face70 reports
- pharyngeal swelling68 reports
Read these as a signal, not a rate. A report does not mean Icatibant Acetate caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Icatibant Acetate head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
icatibant acetate
New